TYROBP facilitates metastatic progression in pancreatic cancer through CTSZ-driven glycolytic rewiring and macrophage recruitment
Cellular Signalling · 2025
DOI: 10.1016/j.cellsig.2025.112142 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2025. Verfasst von Dingwen Zhong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, Ganzhou People's Hospital, Ganzhou, Jiangxi 341000, China. Electronic address: fsgzyy0313@ncu.edu…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Glycolysis, Carcinoma, Pancreatic Ductal, Adaptor Proteins, Signal Transducing. Die Arbeit nennt 37 Literaturangaben. Gefördert von: State Administration of Traditional Chinese Medicine of the People's Republic of China.
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) remains intractable because metastasis outruns intervention. Here we define TYROBP-a microglial adaptor previously unlinked to PDAC-as a pivotal metastatic driver. Transcriptomic mining and validation across paired human specimens revealed pronounced TYROBP up-regulation that trended with poorer survival. Gain- and loss-of-function studies showed that TYROBP potentiates PDAC cell migration and invasion without influencing proliferative indices in vitro or subcutaneous tumor growth in vivo. Mechanistically, transcription factor SP1 occupies a promoter motif (P1) to enforce TYROBP expression; TYROBP then complexes with cathepsin Z (CTSZ), enhancing CXCL8-mediated tumor-associated macrophage recruitment and activating a pAKT-CD44 axis independent of epithelial-to-mesenchymal transition while simultaneously accelerating glycolysis. The flavonoid baicalein engages TYROBP directly, abrogates CTSZ/pAKT/CD44 signaling, and curtails hepatic metastasis in mice without systemic toxicity. TYROBP knock-down blunts dissemination, whereas enforced TYROBP expression exacerbates metastasis-effects reversed by baicalein. Thus, the SP1-TYROBP-CTSZ axis licenses PDAC metastasis, and baicalein-mediated TYROBP inhibition offers a tractable therapeutic strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary and Pancreatic Surgery, Ganzhou People's Hospital, Ganzhou, Jiangxi 341000, China. Electronic address: fsgzyy0313@ncu.edu.cn.
- Department of Hepatobiliary and Pancreatic Surgery, Ganzhou People's Hospital, Ganzhou, Jiangxi 341000, China.
- Shaoguan First People's Hospital, Shaoguan, Guangdong 512000, China.
Förderung
- State Administration of Traditional Chinese Medicine of the People's Republic of China
Zitieren
APA
Zhong, D., Liao, Y., Huang, X., Chen, W., Liu, J., & Fu, X. (2025). TYROBP facilitates metastatic progression in pancreatic cancer through CTSZ-driven glycolytic rewiring and macrophage recruitment. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2025.112142
Vancouver
Zhong D, Liao Y, Huang X, Chen W, Liu J, Fu X. TYROBP facilitates metastatic progression in pancreatic cancer through CTSZ-driven glycolytic rewiring and macrophage recruitment. Cellular Signalling. 2025. doi:10.1016/j.cellsig.2025.112142
BibTeX
@article{Zhong2025,
author = {Zhong, Dingwen and Liao, Yonghui and Huang, Xianyu and Chen, Wenhui and Liu, Jiaxin and Fu, Xinsong},
title = {TYROBP facilitates metastatic progression in pancreatic cancer through CTSZ-driven glycolytic rewiring and macrophage recruitment},
journal = {Cellular Signalling},
year = {2025},
doi = {10.1016/j.cellsig.2025.112142}
}
EUVIMED